What is VASO CORPORATION's earnings per share (EPS)?

VASO CORPORATION (VASO) reported diluted earnings per share of $0.01 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

VASO CORPORATION (VASO) Financials

VASO

Trailing 12 months to June 30, 2026

Revenue $80.2M -8.0% YoY

Net Income $2.5M +924.4% YoY

EPS (Diluted) $0.01 YoY not available

Operating Cash Flow $7.9M +0.9% YoY

Market Cap $51.9M as of Sep 11, 2026

Price / Sales 0.6x on $80.2M revenue, trailing 12 months to June 30, 2026

Price / Earnings 20.8x on $2.5M net income, trailing 12 months to June 30, 2026

Price / Book 1.8x on $29.2M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 14, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VASO SEC filings page.

VASO CORPORATION (VASO) reported $80.2M in revenue over the twelve months to Jun 30, 2026, down 8.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI VASO FY2025 2026-08-30

Stable gross margins cannot offset SG&A expansion, leaving Vaso with positive reported earnings but negative operating profit.

In FY2025, a tax benefit of -$2.9M helped turn a negative operating result of -$2.9M into reported profitability, so bottom-line earnings overstate the operating picture. The same year produced net income of $1.6M alongside operating cash flow of $9.3M, indicating cash generation was not explained by reported profit alone.

Gross margin stayed near 60% from FY2022 through FY2025, so the central pressure was not direct production cost but what happened below gross profit. SG&A rose from $40.8M in FY2022 to $52.2M in FY2025, absorbing added gross profit rather than converting scale into operating income.

The current ratio improved from 0.9x in FY2021 to 1.6x in FY2025, pointing to a stronger short-term asset cushion even as operating profitability turned negative. Equity expanded from $11.1M to $29.4M over the same span, while retained earnings remained negative, indicating the balance-sheet improvement did not erase accumulated deficits.

Financial Health Signals

Financial health score not available

VASO CORPORATION does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

1.21

VASO CORPORATION scores 1.21, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

6/8

VASO CORPORATION passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

5.91x

For every $1 of reported earnings, VASO CORPORATION generates $5.91 in operating cash flow ($9.3M OCF vs $1.6M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage At Risk

N/A

VASO CORPORATION reported an operating loss of $2.9M against $25K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$11.2M

YoY-43.9%

QoQ-42.2%

5Y CAGR-7.1%

10Y CAGR-4.8%

VASO CORPORATION generated $11.2M in revenue in Q2 2026. This represents a decrease of 43.9% from the same quarter a year earlier. Against the prior quarter it is down 42.2%.

EBITDA

$1.2M

YoY+322.1%

QoQ+210.7%

10Y CAGR+4.3%

VASO CORPORATION's EBITDA was $1.2M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 322.1% from the same quarter a year earlier. Against the prior quarter it is up 210.7%.

Net Income

$544K

YoY+376.1%

QoQ+161.3%

5Y CAGR-27.8%

10Y CAGR+9.8%

VASO CORPORATION reported $544K in net income in Q2 2026. This represents an increase of 376.1% from the same quarter a year earlier. Against the prior quarter it is up 161.3%.

EPS (Diluted)

$0.00

QoQ+100.0%

VASO CORPORATION earned $0.00 per diluted share (EPS) in Q2 2026. Against the prior quarter it is up 100.0%.

Cash & Balance Sheet

Free Cash Flow

$16.9M

YoY+169.3%

QoQ+229.5%

VASO CORPORATION generated $16.9M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 169.3% from the same quarter a year earlier. Against the prior quarter it is up 229.5%.

Cash & Debt

$38.3M

YoY+17.6%

QoQ+74.3%

5Y CAGR+32.4%

10Y CAGR+21.1%

VASO CORPORATION held $38.3M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

176M

YoY+0.2%

QoQ0.0%

5Y CAGR+0.1%

10Y CAGR+0.7%

VASO CORPORATION had 176M shares outstanding in Q2 2026. This represents an increase of 0.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

79.5%

YoY+39.7pp

QoQ+19.7pp

5Y change+25.9pp

10Y change+23.9pp

VASO CORPORATION's gross margin was 79.5% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 39.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 19.7 percentage points.

Operating Margin

8.7%

YoY+8.2pp

QoQ+15.6pp

5Y change+13.2pp

10Y change+7.3pp

VASO CORPORATION's operating margin was 8.7% in Q2 2026, reflecting core business profitability. This is up 8.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 15.6 percentage points.

Net Margin

4.9%

YoY+5.8pp

QoQ+9.4pp

5Y change-12.4pp

10Y change+3.7pp

VASO CORPORATION's net profit margin was 4.9% in Q2 2026, showing the share of revenue converted to profit. This is up 5.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 9.4 percentage points.

Return on Equity

1.9%

YoY+2.6pp

QoQ+5.0pp

5Y change-36.4pp

10Y change+0.1pp

VASO CORPORATION's ROE was 1.9% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 2.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.0 percentage points.

Capital Allocation

R&D Spending

$212K

YoY+26.9%

QoQ+15.8%

5Y CAGR+4.5%

10Y CAGR+7.3%

VASO CORPORATION invested $212K in research and development in Q2 2026. This represents an increase of 26.9% from the same quarter a year earlier. Against the prior quarter it is up 15.8%.

Capital Expenditures

$504K

YoY0.0%

QoQ+9.8%

VASO CORPORATION invested $504K in capex in Q2 2026, funding long-term assets and infrastructure. That is unchanged from the same quarter a year earlier. Against the prior quarter it is up 9.8%.

Share Buybacks

Not reported for Q2 2026.

VASO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VASO quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$80.2M	$89.1M+2.7%	$86.8M+7.1%	$81.0M+2.2%	$79.3M+4.9%	$75.6M+8.2%	$69.8M-7.5%	$75.5M+2.1%	$74.0M+1.6%	$72.8M+0.3%	$72.6M+27.2%	$57.1M+63.3%	$35.0M+6.3%	$32.9M+12.5%	$29.2M-6.0%	$31.1M
Cost of Revenue	$34.0M	$34.4M-0.8%	$34.7M+14.1%	$30.4M-3.5%	$31.5M-2.8%	$32.4M+3.7%	$31.3M-5.5%	$33.1M+0.7%	$32.9M+2.5%	$32.1M+3.1%	$31.1M+43.2%	$21.7M+122.4%	$9.8M-5.9%	$10.4M+20.0%	$8.6M	N/A
Gross Profit	$55.8M	$54.7M+5.0%	$52.0M+2.9%	$50.6M+5.6%	$47.9M+11.1%	$43.1M+11.8%	$38.6M-9.1%	$42.4M+3.2%	$41.1M+1.0%	$40.7M-1.9%	$41.5M+17.3%	$35.4M+40.4%	$25.2M+11.9%	$22.5M+9.3%	$20.6M-6.0%	$21.9M
R&D Expenses	$778K	$728K-14.5%	$851K+12.7%	$755K+24.8%	$605K-64.8%	$1.7M+131.0%	$745K-8.4%	$813K-8.2%	$886K-6.2%	$945K+78.3%	$530K+2.9%	$515K-35.9%	$803K+16.5%	$689K+19.6%	$576K	N/A
SG&A Expenses	$52.5M	$52.2M+6.6%	$49.0M+8.7%	$45.1M+10.4%	$40.8M+5.8%	$38.6M+4.2%	$37.1M-9.7%	$41.0M-6.7%	$44.0M+0.8%	$43.6M+10.7%	$39.4M+27.5%	$30.9M+32.5%	$23.3M+0.9%	$23.1M-1.8%	$23.5M	N/A
Operating Income	-$2.1M	-$2.9M-1114.4%	$285K-93.2%	$4.2M-35.0%	$6.5M+128.9%	$2.8M+265.2%	$772K+30.6%	$591K+115.9%	-$3.7M+2.8%	-$3.8M-345.0%	$1.6M-60.3%	$3.9M+270.6%	$1.1M+182.4%	-$1.3M+63.2%	-$3.5M-194.8%	$3.7M
EBITDA	N/A	-$2.0M-283.3%	$1.1M-78.6%	$5.2M-38.0%	$8.4M+25.8%	$6.7M+105.9%	$3.2M-1.2%	$3.3M+372.2%	-$1.2M+14.5%	-$1.4M-137.8%	$3.7M-32.1%	$5.5M+258.1%	$1.5M+264.7%	-$929K+70.2%	-$3.1M	N/A
Interest Expense	N/A	$25K+525.0%	$4K-92.0%	$50K+13.6%	$44K-85.9%	$312K-55.5%	$701K-29.4%	$993K+32.4%	$750K+11.3%	$674K+3.7%	$650K	N/A	N/A	N/A	$2K	N/A
Income Tax	-$2.7M	-$2.9M-981.9%	$326K+226.0%	$100K+102.1%	-$4.7M-3241.1%	$151K+15000.0%	$1K-99.1%	$111K+128.8%	-$385K-387.3%	$134K-52.3%	$281K+738.6%	-$44K-134.6%	$127K+319.0%	-$58K-211.5%	$52K	N/A
Net Income	$2.5M	$1.6M+65.0%	$951K-80.2%	$4.8M-57.5%	$11.3M+85.1%	$6.1M+1603.9%	$358K+193.7%	-$382K+89.8%	-$3.7M+17.7%	-$4.5M-653.5%	$820K-78.6%	$3.8M+238.9%	$1.1M+198.5%	-$1.1M+66.1%	-$3.4M-193.0%	$3.6M
EPS (Basic)	N/A	$0.010.0%	$0.01-66.7%	$0.03-57.1%	$0.07+75.0%	$0.04	$0.00	$0.00+100.0%	-$0.02	N/A	N/A	$0.02+100.0%	$0.01+200.0%	-$0.01+50.0%	-$0.02-200.0%	$0.02
EPS (Diluted)	$0.01	$0.01	$0.01	$0.03-50.0%	$0.06	N/A	$0.00	$0.00+100.0%	-$0.02	N/A	N/A	$0.02	$0.01+200.0%	-$0.01+50.0%	-$0.02-200.0%	$0.02
Diluted Shares (Avg)	N/A	176M	176M	176M+0.5%	175M+0.5%	174M+101612.1%	170,846+1.8%	167,843+1.5%	165,420-99.9%	162M+1.8%	159M+1.4%	157M	156M-2.1%	159M+0.6%	158M+112284.9%	140,914

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$11.2M-43.9%	$19.4M-0.5%	$27.0M-0.1%	$22.7M+9.1%	$20.0M-1.3%	$19.5M+3.9%	$27.0M+21.7%	$20.8M+6.8%
Cost of Revenue	$2.3M-3.8%	$7.8M-4.0%	$15.2M+54.6%	$8.8M-2.8%	$2.4M-70.4%	$8.1M+3.6%	$9.8M+23.8%	$9.0M+21.7%
Gross Profit	$8.9M+11.9%	$11.6M+1.9%	$21.5M+24.7%	$13.9M+18.2%	$7.9M-34.6%	$11.4M+4.0%	$17.2M+20.5%	$11.8M-2.4%
R&D Expenses	$212K+26.9%	$183K+2.8%	$237K-10.2%	$146K-23.6%	$167K-18.5%	$178K-6.8%	$264K+53.5%	$191K-8.6%
SG&A Expenses	$7.7M+0.3%	$12.7M+2.6%	$19.9M+35.7%	$12.2M+7.0%	$7.7M-29.1%	$12.4M+2.8%	$14.7M+18.4%	$11.4M+4.8%
Operating Income	$974K+947.3%	-$1.3M-9.2%	-$3.3M-253.7%	$1.5M+210.4%	$93K-90.7%	-$1.2M+17.0%	$2.1M+77.8%	-$1.4M-253.6%
EBITDA	$1.2M+322.1%	-$1.1M-2.7%	-$3.0M-227.0%	$1.7M+246.3%	$285K-76.7%	-$1.1M+17.5%	$2.3M+62.1%	-$1.2M-203.7%
Income Tax	$387K+1282.1%	-$188K-570.0%	-$3.0M-1831.4%	$35K+16.7%	$28K-75.0%	$40K+233.3%	$172K+164.6%	$30K+87.5%
Net Income	$544K+376.1%	-$887K+17.5%	$1.1M-47.4%	$1.7M+244.9%	-$197K-117.1%	-$1.1M+8.4%	$2.1M+98.9%	-$1.2M-198.6%
EPS (Basic)	$0.00	-$0.010.0%	$0.01-50.0%	$0.01+200.0%	$0.00-100.0%	-$0.010.0%	$0.02+100.0%	-$0.01-200.0%
EPS (Diluted)	$0.00	-$0.010.0%	$0.01-50.0%	$0.01+200.0%	$0.00-100.0%	-$0.010.0%	$0.02+100.0%	-$0.01-200.0%
Diluted Shares (Avg)	176M+0.3%	175,953+0.1%	N/A	176M+0.3%	176M-0.1%	175,696-99.9%	N/A	175M-0.2%

Not reported in any period shown, so not listed: Interest Expense.

VASO Balance Sheet

VASO quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$88.3M+6.5%	$82.9M+9.5%	$75.8M+5.7%	$71.6M+36.8%	$52.4M+3.9%	$50.4M-7.3%	$54.4M+7.7%	$50.5M-11.1%	$56.8M-1.1%	$57.4M+13.8%	$50.4M+23.0%	$41.0M+22.3%	$33.5M+3.5%	$32.4M-5.7%	$34.3M
Current Assets	$58.6M+14.4%	$51.2M+13.5%	$45.1M+10.0%	$41.0M+47.4%	$27.8M+24.9%	$22.3M-7.4%	$24.1M+25.5%	$19.2M-24.8%	$25.5M+1.6%	$25.1M+33.7%	$18.8M-35.3%	$29.0M+11.8%	$25.9M+0.8%	$25.7M-7.1%	$27.7M
Cash & Equivalents	$34.1M+29.7%	$26.3M+131.6%	$11.3M-4.1%	$11.8M+96.2%	$6.0M-11.6%	$6.8M+221.0%	$2.1M-20.4%	$2.7M-49.1%	$5.2M-26.0%	$7.1M+228.1%	$2.2M-76.3%	$9.1M+14.7%	$8.0M-30.6%	$11.5M+400.0%	$2.3M
Short-Term Investments	$0	$0-100.0%	$14.0M+64.4%	$8.5M+1252.0%	$629K-17.9%	$766K	$0	$0	$0	$0-100.0%	$38K-65.8%	$111K0.0%	$111K+0.9%	$110K0.0%	$110K
Inventory	$833K-8.6%	$911K-38.0%	$1.5M-0.2%	$1.5M+28.4%	$1.1M-17.1%	$1.4M-28.7%	$1.9M-2.1%	$2.0M-15.8%	$2.4M-1.7%	$2.4M+22.0%	$2.0M+3.4%	$1.9M+17.3%	$1.6M-25.3%	$2.2M-10.5%	$2.4M
Accounts Receivable	N/A	$350K	N/A	$21.5M+1.2%	$21.2M+51.8%	$14.0M-30.6%	$20.1M+33.9%	$15.0M-16.8%	$18.1M+9.6%	$16.5M+8.0%	$15.3M-22.7%	$19.7M+14.9%	$17.2M+40.8%	$12.2M-44.9%	$22.1M
Long-Term Investments	$0	$0	$0-100.0%	$889K-14.8%	$1.0M-6.5%	$1.1M	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.2M+4.2%	$1.2M-92.5%	$15.6M-0.2%	$15.6M-0.7%	$15.7M0.0%	$15.7M-9.0%	$17.3M-0.2%	$17.3M-0.9%	$17.5M+1.1%	$17.3M-1.2%	$17.5M+431.8%	$3.3M-0.5%	$3.3M+2.8%	$3.2M+1.4%	$3.2M
Total Liabilities	$58.9M+6.7%	$55.2M+12.9%	$48.9M-1.3%	$49.6M+20.1%	$41.3M-8.9%	$45.3M-9.5%	$50.0M+9.0%	$45.9M-3.6%	$47.6M+7.1%	$44.5M+15.0%	$38.7M+16.4%	$33.2M+22.9%	$27.1M+15.8%	$23.4M+1.4%	$23.1M
Current Liabilities	$36.8M+6.1%	$34.7M+15.6%	$30.0M-4.7%	$31.5M+1.6%	$31.0M-2.2%	$31.7M-4.0%	$33.0M-6.6%	$35.4M+4.9%	$33.7M+31.4%	$25.6M+14.3%	$22.4M+14.2%	$19.7M+2.4%	$19.2M+5.7%	$18.2M+10.1%	$16.5M
Non-Current Liabilities	$22.1M+7.6%	$20.5M+8.7%	$18.9M+4.4%	$18.1M+79.8%	$10.1M-26.1%	$13.6M-20.3%	$17.0M+79.3%	$9.5M-31.7%	$13.9M-26.0%	$18.8M+16.0%	$16.2M+19.6%	$13.6M+73.2%	$7.8M+50.9%	$5.2M-20.7%	$6.6M
Long-Term Debt	N/A	N/A	N/A	$15K-34.8%	$23K-99.6%	$5.8M-29.0%	$8.1M+3222.9%	$245K-95.2%	$5.1M-8.8%	$5.6M-4.5%	$5.8M	$0	N/A	N/A	N/A
Total Equity	$29.4M+6.2%	$27.7M+3.2%	$26.8M+21.6%	$22.1M+99.1%	$11.1M+117.9%	$5.1M+17.9%	$4.3M-5.3%	$4.6M-50.2%	$9.2M-29.1%	$12.9M+10.0%	$11.7M+51.5%	$7.8M+19.9%	$6.5M-28.2%	$9.0M-20.1%	$11.3M
Retained Earnings	-$32.5M+4.6%	-$34.1M+2.7%	-$35.0M+12.1%	-$39.8M+21.7%	-$50.9M+10.7%	-$57.0M+0.6%	-$57.4M-0.7%	-$57.0M-8.9%	-$52.3M-9.5%	-$47.8M+1.7%	-$48.6M+7.3%	-$52.4M+2.1%	-$53.6M-2.2%	-$52.4M-6.8%	-$49.1M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$85.9M+4.0%	$83.0M+6.5%	$88.3M+6.5%	$84.5M+14.2%	$82.6M+14.6%	$77.9M+12.2%	$82.9M+9.5%	$73.9M+1.2%
Current Assets	$55.2M+10.4%	$51.1M+11.2%	$58.6M+14.4%	$51.9M+20.7%	$50.0M+22.2%	$46.0M+17.9%	$51.2M+13.5%	$43.0M-0.5%
Cash & Equivalents	$38.3M+17.6%	$22.0M-13.2%	$34.1M+29.7%	$34.9M+29.9%	$32.6M+26.9%	$25.3M+29.6%	$26.3M+131.6%	$26.8M+142.8%
Short-Term Investments	$0	$0	$0	$0	$0	$0-100.0%	$0-100.0%	$0-100.0%
Inventory	$837K-10.9%	$827K-14.3%	$833K-8.6%	$893K-22.7%	$939K-22.9%	$965K-38.4%	$911K-38.0%	$1.2M-17.3%
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	$350K	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$1.3M-91.9%	$11.0M-29.4%	$1.2M+4.2%	$15.6M-0.1%	$15.6M+0.1%	$15.6M0.0%	$1.2M-92.5%	$15.6M+0.3%
Total Liabilities	$56.7M+1.1%	$54.4M+6.1%	$58.9M+6.7%	$56.2M+16.5%	$56.1M+23.7%	$51.3M+16.9%	$55.2M+12.9%	$48.3M+1.8%
Current Liabilities	$32.9M-0.5%	$30.6M+1.1%	$36.8M+6.1%	$31.6M+4.7%	$33.0M+23.0%	$30.2M+10.9%	$34.7M+15.6%	$30.2M-0.4%
Non-Current Liabilities	$23.8M+3.4%	$23.8M+13.3%	$22.1M+7.6%	$24.6M+36.0%	$23.1M+24.6%	$21.0M+26.7%	$20.5M+8.7%	$18.1M+5.8%
Total Equity	$29.2M+10.2%	$28.6M+7.3%	$29.4M+6.2%	$28.2M+10.0%	$26.5M-0.8%	$26.6M+4.2%	$27.7M+3.2%	$25.7M+0.2%
Retained Earnings	-$32.9M+7.1%	-$33.4M+5.0%	-$32.5M+4.6%	-$33.6M+7.1%	-$35.4M-0.9%	-$35.2M+2.9%	-$34.1M+2.7%	-$36.2M-0.3%

Not reported in any period shown, so not listed: Long-Term Debt.

VASO Cash Flow Statement

VASO quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$7.9M	$9.3M+182.6%	$3.3M-38.0%	$5.3M-63.3%	$14.4M+84.5%	$7.8M+31.7%	$5.9M+545.2%	-$1.3M+8.3%	-$1.5M-190.9%	$1.6M-69.3%	$5.2M-20.0%	$6.5M+151.3%	$2.6M+272.5%	-$1.5M-115.9%	$9.4M+8172.8%	$114K
Depreciation & Amortization	N/A	$858K+4.1%	$824K-17.5%	$999K-48.0%	$1.9M-49.9%	$3.8M+56.0%	$2.5M-8.2%	$2.7M+6.3%	$2.5M+4.0%	$2.4M+12.4%	$2.2M+40.1%	$1.5M+229.8%	$467K+29.4%	$361K-7.7%	$391K	N/A
Stock-Based Compensation	N/A	$33K-38.9%	$54K+12.5%	$48K+37.1%	$35K+12.9%	$31K-64.8%	$88K-37.6%	$141K-55.0%	$313K-39.1%	$514K+20.1%	$428K+25.1%	$342K-12.3%	$390K+5.7%	$369K-53.5%	$793K	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	$566K+36.4%	$415K-58.5%	$1.0M-17.0%	$1.2M-53.4%	$2.6M+8.9%	$2.4M+27.2%	$1.9M+109.0%	$893K+129.6%	$389K+70.6%	$228K-43.3%	$402K	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	$13.8M+87.2%	$7.4M+50.0%	$4.9M+294.4%	-$2.5M+37.2%	-$4.0M-421.2%	-$775K-123.1%	$3.3M-40.5%	$5.6M+155.2%	$2.2M+227.3%	-$1.7M-119.2%	$9.0M	N/A
Investing Cash Flow	-$821K	-$725K-106.2%	$11.7M+307.4%	-$5.7M+32.8%	-$8.4M-3137.3%	-$260K+54.8%	-$575K+51.4%	-$1.2M+48.0%	-$2.3M+4.2%	-$2.4M-5.5%	-$2.3M	N/A	N/A	-$228K+43.3%	-$402K+41.1%	-$682K
Financing Cash Flow	N/A	$248K+378.7%	-$89K+33.6%	-$134K+41.7%	-$230K+97.2%	-$8.3M-1406.1%	-$553K-129.0%	$1.9M+67.3%	$1.1M+208.5%	-$1.1M-154.8%	$1.9M	N/A	N/A	-$1.8M-1247.1%	$153K+164.3%	-$238K
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$245K-86.0%	$1.8M	$0	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$17.4M+156.7%	-$12.6M-2130.6%	$261K+171.1%	$2.8M+44.2%	$6.8M+143.7%	-$566K+47.1%	-$367K+76.5%	$1.9M+129.5%
Depreciation & Amortization	$229K+19.3%	$243K+51.9%	$327K+68.6%	$179K-18.3%	$192K-15.0%	$160K-13.5%	$194K-18.1%	$219K-2.7%
Stock-Based Compensation	N/A	$8K0.0%	N/A	N/A	N/A	$8K-11.1%	N/A	N/A
Capital Expenditures	$504K0.0%	$459K+26.4%	N/A	N/A	$504K	$363K	N/A	N/A
Free Cash Flow	$16.9M+169.3%	-$13.1M-1308.4%	N/A	N/A	$6.3M	-$929K	N/A	N/A
Investing Cash Flow	-$504K0.0%	-$459K-26.4%	-$83K+62.8%	$225K+133.4%	-$504K-114.5%	-$363K-104.0%	-$223K-111.9%	-$673K+83.9%
Financing Cash Flow	N/A	N/A	$2K+109.1%	-$690K-2364.3%	$963K+701.9%	-$27K-122.3%	-$22K+18.5%	-$28K-300.0%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

VASO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

VASO quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	61.4%+1.4pp	60.0%-2.4pp	62.4%+2.0pp	60.4%+3.3pp	57.1%+1.8pp	55.2%-1.0pp	56.2%+0.6pp	55.6%-0.4pp	56.0%-1.2pp	57.2%-4.8pp	62.0%-10.1pp	72.1%+3.6pp	68.5%-2.0pp	70.4%0.0pp	70.5%
Operating Margin	-3.2%-3.6pp	0.3%-4.9pp	5.2%-3.0pp	8.1%+4.4pp	3.7%+2.6pp	1.1%+0.3pp	0.8%+5.8pp	-5.0%+0.2pp	-5.3%-7.4pp	2.1%-4.8pp	6.9%+3.9pp	3.0%+7.0pp	-3.9%+8.1pp	-12.0%-23.9pp	11.9%
Net Margin	1.8%+0.7pp	1.1%-4.8pp	5.9%-8.3pp	14.2%+6.2pp	8.1%+7.6pp	0.5%+1.0pp	-0.5%+4.5pp	-5.1%+1.2pp	-6.2%-7.4pp	1.1%-5.6pp	6.7%+3.5pp	3.2%+6.7pp	-3.5%+8.1pp	-11.6%-23.2pp	11.7%
Return on Equity	5.3%+1.9pp	3.4%-14.5pp	17.9%-33.3pp	51.2%-3.9pp	55.0%+48.0pp	7.0%+15.9pp	-8.8%+73.1pp	-81.9%-32.3pp	-49.6%-56.0pp	6.3%-26.2pp	32.6%+18.0pp	14.5%+32.3pp	-17.7%+19.8pp	-37.5%-69.8pp	32.2%
Return on Assets	1.8%+0.6pp	1.1%-5.2pp	6.3%-9.4pp	15.8%+4.1pp	11.7%+10.9pp	0.7%+1.4pp	-0.7%+6.7pp	-7.4%+0.6pp	-8.0%-9.4pp	1.4%-6.2pp	7.6%+4.8pp	2.8%+6.2pp	-3.4%+7.0pp	-10.4%-21.0pp	10.6%
Current Ratio	1.59+0.1x	1.470.0x	1.50+0.2x	1.30+0.4x	0.90+0.2x	0.700.0x	0.73+0.2x	0.54-0.2x	0.76-0.2x	0.98+0.1x	0.84-0.6x	1.47+0.1x	1.35-0.1x	1.41-0.3x	1.68
Debt-to-Equity	2.000.0x	1.99+0.2x	1.82+1.8x	0.000.0x	0.00-1.1x	1.14-0.8x	1.89+1.8x	0.05-0.5x	0.56+0.1x	0.43-0.1x	0.50+0.5x	0.00-4.2x	4.18+1.6x	2.59+0.5x	2.04
Asset Turnover	1.010.0x	1.050.0x	1.070.0x	1.11-0.3x	1.44+0.1x	1.390.0x	1.39-0.1x	1.47+0.2x	1.280.0x	1.26+0.1x	1.13+0.3x	0.85-0.1x	0.98+0.1x	0.900.0x	0.91
FCF Margin	N/A	N/A	N/A	17.5%+7.7pp	9.8%+2.7pp	7.1%+10.4pp	-3.4%+2.1pp	-5.5%-4.4pp	-1.1%-5.7pp	4.6%-5.2pp	9.9%+3.5pp	6.3%+11.6pp	-5.3%-36.2pp	30.9%	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	79.5%+39.7pp	59.8%+1.4pp	79.5%+15.8pp	61.3%+4.7pp	39.8%-20.3pp	58.4%+0.1pp	63.7%-0.6pp	56.6%-5.3pp
Operating Margin	8.7%+8.2pp	-6.9%-0.6pp	-12.2%-20.2pp	6.8%+13.5pp	0.5%-4.5pp	-6.3%+1.6pp	8.0%+2.5pp	-6.7%-11.4pp
Net Margin	4.9%+5.8pp	-4.6%+0.9pp	4.2%-3.8pp	7.5%+13.2pp	-1.0%-6.7pp	-5.5%+0.7pp	8.0%+3.1pp	-5.7%-11.8pp
Return on Equity	1.9%+2.6pp	-3.1%+0.9pp	3.8%-3.9pp	6.1%+10.7pp	-0.7%-5.1pp	-4.0%+0.6pp	7.8%+3.7pp	-4.6%-9.3pp
Return on Assets	0.6%+0.9pp	-1.1%+0.3pp	1.3%-1.3pp	2.0%+3.6pp	-0.2%-1.8pp	-1.4%+0.3pp	2.6%+1.2pp	-1.6%-3.2pp
Current Ratio	1.68+0.2x	1.67+0.2x	1.59+0.1x	1.64+0.2x	1.510.0x	1.52+0.1x	1.470.0x	1.430.0x
Debt-to-Equity	1.94-0.2x	1.900.0x	2.000.0x	1.99+0.1x	2.12+0.4x	1.92+0.2x	1.99+0.2x	1.880.0x
Asset Turnover	0.13-0.1x	0.230.0x	0.310.0x	0.270.0x	0.240.0x	0.250.0x	0.330.0x	0.280.0x
FCF Margin	151.4%	-67.6%-62.8pp	N/A	N/A	31.5%	-4.8%	N/A	N/A

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
VASO CORPORATION VASO	FY2025	$89.1M	$1.6M	1.8%	$51.9M	—
RENALYTIX PLC SP/ADR RNLXY	FY2024	$2.3M	-$33.5M	N/A	$50.1M	—
RETRIEVE MEDICAL HLDG INC RMHI	FY2022	N/A	-$165K	N/A	$29.2M	—
PHARM-BIO SERV INC PBSV	FY2025	$9.0M	-$100K	-1.1%	$12.4M	—

Where VASO CORPORATION Ranks

Frequently Asked Questions

What is VASO CORPORATION's annual revenue?

VASO CORPORATION (VASO) reported $89.1M in total revenue for fiscal year 2025. This represents a 2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is VASO CORPORATION's revenue growing?

VASO CORPORATION (VASO) revenue grew by 2.7% year-over-year, from $86.8M to $89.1M in fiscal year 2025.

Is VASO CORPORATION profitable?

Yes, VASO CORPORATION (VASO) reported a net income of $1.6M in fiscal year 2025, with a net profit margin of 1.8%.

What is VASO CORPORATION's EBITDA?

VASO CORPORATION (VASO) had EBITDA of -$2.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is VASO CORPORATION's gross margin?

VASO CORPORATION (VASO) had a gross margin of 61.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is VASO CORPORATION's operating margin?

VASO CORPORATION (VASO) had an operating margin of -3.2% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is VASO CORPORATION's net profit margin?

VASO CORPORATION (VASO) had a net profit margin of 1.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is VASO CORPORATION's return on equity (ROE)?

VASO CORPORATION (VASO) has a return on equity of 5.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is VASO CORPORATION's operating cash flow?

VASO CORPORATION (VASO) generated $9.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are VASO CORPORATION's total assets?

VASO CORPORATION (VASO) had $88.3M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does VASO CORPORATION spend on research and development?

VASO CORPORATION (VASO) invested $728K in research and development during fiscal year 2025.

How many shares does VASO CORPORATION have outstanding?

VASO CORPORATION (VASO) had 176M shares outstanding as of fiscal year 2025.

What is VASO CORPORATION's current ratio?

VASO CORPORATION (VASO) had a current ratio of 1.59 as of fiscal year 2025, which is generally considered healthy.

What is VASO CORPORATION's debt-to-equity ratio?

VASO CORPORATION (VASO) had a debt-to-equity ratio of 2.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is VASO CORPORATION's return on assets (ROA)?

VASO CORPORATION (VASO) had a return on assets of 1.8% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is VASO CORPORATION's P/E ratio?

VASO CORPORATION (VASO) trades at 20.8x earnings, its market capitalization divided by net income of $2.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $51.9M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is VASO CORPORATION's price-to-sales ratio?

VASO CORPORATION (VASO) trades at 0.6x sales, its market capitalization divided by revenue of $80.2M revenue, trailing 12 months to June 30, 2026. The market capitalization is $51.9M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is VASO CORPORATION's Altman Z-Score?

VASO CORPORATION (VASO) has an Altman Z-Score of 1.21, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is VASO CORPORATION's Piotroski F-Score?

VASO CORPORATION (VASO) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are VASO CORPORATION's earnings high quality?

VASO CORPORATION (VASO) has an earnings quality ratio of 5.91x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can VASO CORPORATION cover its interest payments?

VASO CORPORATION (VASO) reported an operating loss of $2.9M against $25K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.